2486-63-7

Basic information

• Product Name: 2-ethoxy-1-methyl-4-nitrobenzene
• Synonyms: 2-ethoxy-1-methyl-4-nitrobenzene
• CAS NO: 2486-63-7
• Molecular Weight: 181.191
• Mol File: 2486-63-7.mol

Chemical Properties

• CAS DataBase Reference: 2-ethoxy-1-methyl-4-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-ethoxy-1-methyl-4-nitrobenzene(2486-63-7)
• EPA Substance Registry System: 2-ethoxy-1-methyl-4-nitrobenzene(2486-63-7)

Safety Data

• Hazardous Substances Data: 2486-63-7(Hazardous Substances Data)

Upstream product

• 95-49-8 2-methylchlorobenzene 
• 64-17-5 ethanol 
• 121-86-8 2-chloro-4-nitrotoluene 
• 5428-54-6 2-methyl-5-nitrophenol 
• 75-03-6 ethyl iodide 
• 80-40-0 ethyl ester of p-toluenesulfonic acid 
• 64-67-5 diethyl sulfate 
• 74-96-4 ethyl bromide 

Downstream Products

• 1312613-02-7 (2-ethoxy-4-nitrobenzyl)triphenylphosphonium bromide 
• 1311136-97-6 (5R)-5-ethyl-3-(2-{[3-(ethyloxy)-4-methylphenyl]oxy}-5-pyrimidinyl)-2,4-imidazolidinedione 
• 1311138-49-4 (2R)-2-amino-N-(2-{[3-(ethyloxy)-4-methylphenyl]oxy}-5-pyrimidinyl)butanamide 
• 1311138-48-3 1,1-dimethylethyl ((1R)-1-{[(2-{[3-(ethyloxy)-4-methylphenyl]oxy}-5-pyrimidinyl)amino]carbonyl}propyl)carbamate 
• 1311138-47-2 2-{[3-(ethyloxy)-4-methylphenyl]oxy}-5-pyrimidinamine 
• 1311138-46-1 2-{[3-(ethyloxy)-4-methylphenyl]oxy}-5-nitropyrimidine 
• 676224-74-1 3-ethoxy-4-methyl-phenol 
• 855468-81-4 2-ethoxy-4,5-dinitro-benzoyl chloride 
• 408328-89-2 2-ethoxy-4,5-dinitro-benzoic acid 
• 409317-52-8 2-ethoxy-4-hydrazino-5-nitro-benzoic acid 
• 103797-33-7 2,4-diethoxy-5-nitro-benzoic acid 

Relevant articles and documents

Novel preparation method of mosapride

The invention discloses a novel preparation method of mosapride.Cheap 2-chlorotoluene is used as an initial raw material is subjected to nitration, nucleophilic substitution, free radical bromination, chlorination, alkylation, nitro reduction and oxidative amidation to synthesize mosapride. According to the scheme, raw materials are easy to obtain, dangerous processes and highly toxic reagents are avoided, the method is green and environment-friendly, oxidation amidation is adopted, selectivity is achieved, formation of aromatic amide by-products is avoided, and the yield is high.

Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity

Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.

IMIDAZOLIDINEDIONE DERIVATIVES

The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizopherenea, substance abuse disorders, sleep disorders or epilepsy.